Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Shares Issued (2021 - 2025)

Barinthus Biotherapeutics (BRNS) has disclosed Shares Issued for 4 consecutive years, with $2000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Shares Issued fell 99.77% year-over-year to $2000.0, compared with a TTM value of $839000.0 through Sep 2025, down 36.73%, and an annual FY2024 reading of $2.2 million, changed N/A over the prior year.
  • Shares Issued was $2000.0 for Q2 2025 at Barinthus Biotherapeutics, down from $837000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $102.8 million in Q3 2021 and bottomed at -$102.8 million in Q4 2021.
  • Average Shares Issued over 4 years is $379714.3, with a median of $484000.0 recorded in 2022.
  • The sharpest move saw Shares Issued skyrocketed 100.47% in 2022, then crashed 99.77% in 2025.
  • Year by year, Shares Issued stood at -$102.8 million in 2021, then surged by 100.47% to $484000.0 in 2022, then soared by 72.93% to $837000.0 in 2024, then crashed by 99.76% to $2000.0 in 2025.
  • Business Quant data shows Shares Issued for BRNS at $2000.0 in Q2 2025, $837000.0 in Q4 2024, and $465000.0 in Q3 2024.